Introduction Cervical cancer is the leading cause of cancer deaths in women in the
developing world. New technologies have been developed to allow for more rapid, cost …

Cervical cancer (CC) represents the fourth most common malignancy affecting women all
over the world and is the second most common in developing areas. In these areas, the …

Cervical cancer remains the most common cancer among women living in developing
countries, largely because of the failure either to initiate or sustain effective cervical-cancer …

Cervical cancer is the fourth most common cancer in women in the world. To eliminate
cervical cancer by 2030, the World Health Organization has given the target of 70 per cent …

Objective This study evaluates the feasibility and performance of care HPV, a novel human
papillomavirus (HPV) DNA test, when used for screening women for cervical cancer in low …

Although cytology-based cervical cancer prevention programs have reduced the incidence
of cervical cancer in many industrialized countries, the limited sensitivity of cervical cytology …

Cervical cancer is the most common malignancy amongst females in developing countries,
mainly due to a lack of precursor screening. This absence of screening is the result of …

Objectives ATHENA evaluated the cobas HPV Test as the primary screen for cervical cancer
in women≥ 25 years. This reports the 3-year end-of-study results comparing the …

This paper summarises the position of ESGO and EFC on cervical screening based on
existing guidelines and opinions of a team of lead experts. HPV test is replacing cytology as …

Organised, cytology-based cervical screening has led to a reduction in deaths associated
with cervical cancer. Human papillomavirus (HPV) is necessary for the development of …